Literature DB >> 2472169

Identification of normal B-cell counterparts of neoplastic cells which secrete cold agglutinins of anti-I and anti-i specificity.

F K Stevenson1, G J Smith, J North, T J Hamblin, M J Glennie.   

Abstract

A monoclonal antibody, which recognizes a cross-reacting idiotypic determinant present on human cold-reactive autoantibodies with anti-I or anti-i binding activity, has been found to specifically inhibit the cold agglutination of red cells. This suggests that an epitope close to the binding site of such autoantibodies is being recognized. The antibody has been used to identify tumour cells in the blood of three patients with cold haemagglutinin disease, and to analyse the heterogeneous nature of the neoplastic B-cell clone present in the bone marrow of one of the patients. Using S-phase analysis, it was found that cell proliferation was occurring in the bone marrow but not in the blood, and that the major proliferating population was that of lymphoplasmacytoid cells containing large vesicular inclusions of idiotypic IgM. It has also been possible to locate normal B-cells which are recognized by the anti-idiotypic antibody. Such cells have been found throughout the normal adult lymphoid tissue where they account for 2.9-10.8% of the B lymphocyte population. They are also present in fetal spleen at 15 weeks gestation, indicating that immunoglobulins bearing this sequence form part of the immature B-cell repertoire.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2472169     DOI: 10.1111/j.1365-2141.1989.tb07643.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  18 in total

1.  Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus.

Authors:  Amedeo Cappione; Jennifer H Anolik; Aimee Pugh-Bernard; Jennifer Barnard; Paul Dutcher; Gregg Silverman; Iñaki Sanz
Journal:  J Clin Invest       Date:  2005-10-06       Impact factor: 14.808

2.  Sequence analysis of rearranged IgVH genes from microdissected human Peyer's patch marginal zone B cells.

Authors:  D K Dunn-Walters; P G Isaacson; J Spencer
Journal:  Immunology       Date:  1996-08       Impact factor: 7.397

3.  Superantigen properties of a human sialoprotein involved in gut-associated immunity.

Authors:  G J Silverman; P Roben; J P Bouvet; M Sasano
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

Review 4.  Natural and pathologic human autoimmune responses to carbohydrate antigens on red blood cells.

Authors:  L E Silberstein
Journal:  Springer Semin Immunopathol       Date:  1993

Review 5.  Human innate B cells: a link between host defense and autoimmunity?

Authors:  Eric C B Milner; Jennifer Anolik; Amedeo Cappione; Iñaki Sanz
Journal:  Springer Semin Immunopathol       Date:  2005-01-05

6.  Two acquired immunodeficiency syndrome-associated Burkitt's lymphomas produce specific anti-i IgM cold agglutinins using somatically mutated VH4-21 segments.

Authors:  P Riboldi; G Gaidano; E W Schettino; T G Steger; D M Knowles; R Dalla-Favera; P Casali
Journal:  Blood       Date:  1994-05-15       Impact factor: 22.113

7.  Human immunoglobulin M paraproteins cross-reactive with Neisseria meningitidis group B polysaccharide and fetal brain.

Authors:  F H Azmi; A H Lucas; H L Spiegelberg; D M Granoff
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

8.  Sequence analysis of V(4-34)-encoded antibodies from single B cells of two patients with systemic lupus erythematosus (SLE).

Authors:  C I Mockridge; C J Chapman; M B Spellerberg; B Sheth; T P Fleming; D A Isenberg; F K Stevenson
Journal:  Clin Exp Immunol       Date:  1998-10       Impact factor: 4.330

Review 9.  B-cell anergy: from transgenic models to naturally occurring anergic B cells?

Authors:  John C Cambier; Stephen B Gauld; Kevin T Merrell; Barbara J Vilen
Journal:  Nat Rev Immunol       Date:  2007-07-20       Impact factor: 53.106

10.  VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy.

Authors:  Evgeny Arons; Tara Suntum; Maryalice Stetler-Stevenson; Robert J Kreitman
Journal:  Blood       Date:  2009-09-10       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.